Company / FCF Margin
OCULAR THERAPEUTIX, INC FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-417.5%
FY2025
5-year range
-1888.2% / -130.6%
FY2021-FY2025
Trend
-95.7%
vs FY2024
Sector context
#110 of 133
Health Care
What the data says
OCULAR THERAPEUTIX, INC's fcf margin of -417.5% is lower than 83% of companies in the Health Care sector (FY2025). FCF Margin has fluctuated over the past 10 years, ranging from -3053.8% in FY2019 to -130.6% in FY2023.
Based on SEC 10-K filings.
-417.5% in FY2025 with a 5-year CAGR of +1470.7%.
Declined from -130.6% to -417.5% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -104.9pp
- 5-Year Change
- +1470.7pp
- 10-Year Change
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 133This company -417.5% Sector average -632.8%
▼
+34.0% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 95.7% year-over-year.
- Currently 215.3pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2023.
- Lowest fcf margin in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.25 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -417.5% | -95.7% |
| FY2024 | -213.4% | -63.4% |
| FY2023 | -130.6% | +58.2% |
| FY2022 | -312.6% | +83.4% |
| FY2021 | -1888.2% | +0.0% |
| FY2020 | -1888.2% | +38.2% |
| FY2019 | -3053.8% | -18.9% |
| FY2018 | -2568.6% | +15.9% |
| FY2017 | -3053.8% | -60.4% |
| FY2016 | -1903.5% | -12.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026